Growth Metrics

Pulmonx (LUNG) Current Deferred Revenue (2019 - 2025)

Pulmonx (LUNG) reported Current Deferred Revenue of $18000.0 for Q4 2025, down 82.0% year-over-year from $100000.0 in Q4 2024, and down 80.43% on a QoQ basis from $92000.0 in Q3 2025.

Pulmonx (LUNG) has 7 years of Current Deferred Revenue data on file, last reported at $18000.0 in Q4 2025.

  • Quarterly Current Deferred Revenue fell 82.0% year-over-year to $18000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18000.0 (down 82.0% YoY) and the FY2025 annual result came in at $18000.0, down 82.0% from the prior year.
  • Current Deferred Revenue declined to $18000.0 in Q4 2025 per LUNG's latest filing, from $92000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $200000.0 in Q3 2021 and bottomed at $18000.0 in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $100000.0 (2021), against an average of $108300.0.
  • The widest annual swing landed in 2021, when Current Deferred Revenue soared 117.39%; it then tumbled 82.0% in 2025.
  • Tracing LUNG's Current Deferred Revenue over 5 years: stood at $200000.0 in 2021, then tumbled by 50.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then plunged by 82.0% to $18000.0 in 2025.
  • Per Business Quant, the three latest LUNG Current Deferred Revenue figures stand at $18000.0 (Q4 2025), $92000.0 (Q3 2025), and $100000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Pulmonx 67.30 Mn -2.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 18,000.00
Sep 30, 2025 92,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 107,000.00
Mar 31, 2024 110,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 85,000.00
Jun 30, 2023 100,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 106,000.00
Jun 30, 2022 131,000.00
Mar 31, 2022 132,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 85,000.00
Mar 31, 2021 100,000.00
Dec 31, 2020 100,000.00
Sep 30, 2020 92,000.00
Dec 31, 2019 200,000.00